The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.85BCNY
877.04M · vs all stocks (USD)
Updated Nov 19, 2026
Revenue (TTM)
5.48BCNY
821.81M · vs all stocks (USD)
Updated Nov 19, 2026
Profit Margin
-0.45%
vs Conglomerates peers
Updated Nov 19, 2026
Beta
0.2680x
vs all stocks
Updated Nov 19, 2026
52-Week Change
-34.59%
vs all stocks
Updated Nov 19, 2026
Market Capitalization
5.85BCNY
877.04M · vs all stocks (USD)
Updated Nov 19, 2026
Enterprise Value
6.48BCNY
971.26M · vs all stocks (USD)
Updated Nov 19, 2026
Forward P/E
12.10x
vs Conglomerates peers
Updated Nov 19, 2026
Price to Sales (TTM)
1.07x
vs Conglomerates peers
Updated Nov 19, 2026
Price to Book (MRQ)
1.85x
vs Conglomerates peers
Updated Nov 19, 2026
Enterprise to Revenue
1.18x
vs Conglomerates peers
Updated Nov 19, 2026
Enterprise to EBITDA
25.38x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 9.04×.Updated Nov 19, 2026
Gross Margin
5.48%
vs Conglomerates peers
Updated Nov 19, 2026
Profit Margin
-0.45%
vs Conglomerates peers
Updated Nov 19, 2026
Operating Margin
2.00%
vs Conglomerates peers
Updated Nov 19, 2026
Return on Assets (TTM)
1.05%
vs Conglomerates peers
Updated Nov 19, 2026
Return on Equity (TTM)
-0.38%
vs Conglomerates peers
Updated Nov 19, 2026
Revenue (TTM)
5.48BCNY
821.81M · vs all stocks (USD)
Updated Nov 19, 2026
Revenue per Share (TTM)
2.27CNYUpdated Nov 19, 2026
Quarterly Revenue Growth
-15.30%
vs Conglomerates peers
Updated Nov 19, 2026
Gross Profit (TTM)
217.63MCNY
32.64M · vs all stocks (USD)
Updated Nov 19, 2026
EBITDA (TTM)
716.62MCNY
107.49M · vs all stocks (USD)
Updated Nov 19, 2026
Net Income (TTM)
-24.41MCNY
-3.66M · vs all stocks (USD)
Updated Nov 19, 2026
Quarterly Earnings Growth (YoY)
-9.50%
vs Conglomerates peers
Updated Nov 19, 2026
Operating Cash Flow (TTM)
-848.92MCNY
-127.33M · vs all stocks (USD)
Updated Nov 19, 2026
Levered Free Cash Flow (TTM)
-347.23MCNY
-52.08M · vs all stocks (USD)
Updated Nov 19, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Nov 19, 2026
Minority Interest (Equity)
193.98MCNYFY2025 · Dec 31, 2025
Revenue
7.27BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
7.14BCNYFY2025 · Dec 31, 2025
Gross Profit
134.54MCNYFY2025 · Dec 31, 2025
Operating Income
-294.53KCNY
-44.18K · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
260.61MCNYFY2025 · Dec 31, 2025
Income Tax Expense
4.72MCNYFY2025 · Dec 31, 2025
Net Income
255.90MCNYFY2025 · Dec 31, 2025
EBIT
293.12MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
716.62MCNYFY2025 · Dec 31, 2025
Research & Development
62.03MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
31.60MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
15.36MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
17.22MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
32.50MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0990CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0990CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.51BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.51BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
255.90MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-7.44MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
894.58MCNYFY2025 · Dec 31, 2025
Free Cash Flow
882.48MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
56.08MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
255.90MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
33.21MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
366.92MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
238.56MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-12.10MCNYFY2025 · Dec 31, 2025
Net Acquisitions
113.81MCNYFY2025 · Dec 31, 2025
Sale of Investments
279.90MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-3.20MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
378.41MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
986.07MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-984.27MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-28.19MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-162.05MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-188.45MCNYFY2025 · Dec 31, 2025
Shares Outstanding
2.48BSharesUpdated Nov 19, 2026
Float Shares
1.45BSharesUpdated Nov 19, 2026
% Held by Insiders
39.80%
vs all stocks
Updated Nov 19, 2026
% Held by Institutions
0.00%
vs all stocks
Updated Nov 19, 2026
Total Cash (MRQ)
630.87MCNY
94.62M · vs all stocks (USD)
Updated Nov 19, 2026
Total Cash per Share (MRQ)
0.2650CNYUpdated Nov 19, 2026
Total Debt (MRQ)
1.06BCNY
159.60M · vs all stocks (USD)
Updated Nov 19, 2026
Total Debt to Equity (MRQ)
0.3202x
vs Conglomerates peers
Updated Nov 19, 2026
Current Ratio (MRQ)
1.19x
vs Conglomerates peers
Updated Nov 19, 2026
Book Value per Share (MRQ)
1.31CNYUpdated Nov 19, 2026
Total Assets
6.66BCNY
998.76M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
3.28BCNYFY2025 · Dec 31, 2025
Total Liabilities
3.39BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
3.38BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
327.02MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
3.06BCNYFY2025 · Dec 31, 2025
Cash
658.81MCNYFY2025 · Dec 31, 2025
Cash Equivalents
339.76MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
998.57MCNYFY2025 · Dec 31, 2025
Accounts Receivable
453.80MCNYFY2025 · Dec 31, 2025
Inventory
1.20BCNYFY2025 · Dec 31, 2025
Accounts Payable
1.52BCNYFY2025 · Dec 31, 2025
Short-term Debt
1.04BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
12.37MCNYFY2025 · Dec 31, 2025
Long-term Debt
189.40MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
22.40MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.48BCNYFY2025 · Dec 31, 2025
Retained Earnings
-762.24MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.27BCNY
490.51M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
140.00MCNYFY2025 · Dec 31, 2025
52-Week Low
2.02CNYUpdated Nov 19, 2026
52-Week High
3.85CNYUpdated Nov 19, 2026
52-Week Change
-34.59%
vs all stocks
Updated Nov 19, 2026
Beta
0.2680x
vs all stocks
Updated Nov 19, 2026
50-Day MA
2.53CNYUpdated Nov 19, 2026
200-Day MA
2.64CNYUpdated Nov 19, 2026
Avg 10-Day Volume
12.06MSharesUpdated Nov 19, 2026
Avg 30-Day Volume
9.04MSharesUpdated Nov 19, 2026
Diluted EPS (TTM)
0.0990CNYUpdated Nov 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.15: grey zoneSignificant
Altman Z-Score: 2.15
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Revenue is $821.81M, above the global median of $566.17MNotable